Nichd:r & d:biological testing facility IDIQ:non-severable
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N94020D00003
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Task orders
- 27 $27,169,025 obligated
Award facts
- Opportunity
-
- Biological Testing Facility Pre-Solicitation · NIHNICHDCDP20208 · Posted Jan 23, 2020
- Biological Testing Facility Solicitation · Posted Feb 27, 2020
- Combined order value
-
- $27,169,025 Current, with exercised options
- $28,593,373 Potential, with all options
- Last date to order 84% complete
- IDV ceiling 68% used
- $40,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Child Health and Human Development awarded a single-award indefinite-delivery contract to Sri International on August 30, 2020, with a $40 million ceiling for preclinical biological testing and contraceptive research and development services. Place of performance is Menlo Park, California. The contract extends through November 30, 2027 (base year plus four options). NAICS code 541712 (research and development in the physical, engineering, and life sciences) governs the procurement.
The originating solicitation, posted January 23, 2020, sought state-of-the-art preclinical evaluation capabilities to assess new chemical compounds, formulations, delivery systems, and devices for contraception and therapies under development. Work includes safety, efficacy, toxicity, and pharmacokinetic testing in multiple species to satisfy regulatory standards, product development, lot production, preclinical studies, and IND application compilation. The contractor must conduct evaluations in rodents, rabbits, and non-human primates.
Task-order activity under this IDIQ spans contraceptive research, manufacturing, stability testing, and facility management. Recent significant orders include Task Order 28 for preclinical, manufacturing, and stability studies ($1.493 million, June 1, 2026 through May 31, 2028); Task Order 27 for drug product manufacture of ongoing clinical development ($773,798, awarded August 1, 2025, completing July 31, 2030); Task Order 20 for preclinical development of contraceptive products ($1.017 million, awarded September 27, 2024, completing September 26, 2027); and Task Order 1 for administrative and management services ($2.574 million, September 4, 2020 through September 3, 2025). All task orders are cost-reimbursement structures. Subcontractors on recent orders include Charles River Laboratories for preclinical services and university partners including University of Texas Medical Branch at Galveston, Lundquist Institute for Biomedical Innovation, and Washington State University for specialized research components.
Task orders
Show all 27
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Inotiv, Inc. | $164,952 | |
| Syneos Health LLC | $101,920 | |
| Frey-Tox GMBH | $43,507 | |
| Chemo Research SL | $150,000 | |
| University Of Texas Medical Branch At Galveston | $44,275 | |
| Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | $35,510 | |
| Charles River Laboratories, Inc. | $160,800 | |
| Washington State University | $332,817 |
Quick answers
Who was awarded contract 75N94020D00003?
75N94020D00003 was awarded to Sri International by National Institute of Child Health and Human Development (National Institutes of Health) on August 30, 2020.
How much is contract 75N94020D00003 worth?
Orders under 75N94020D00003 have obligated $27,169,025. Their combined potential value, with all options, is $28,593,373. 75N94020D00003's own ceiling is $40,000,000.
How many orders have been placed under contract 75N94020D00003?
27 orders have been placed under 75N94020D00003, the latest on June 1, 2026.
Who can order from contract 75N94020D00003?
75N94020D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N94020D00003 competed?
The extent of competition for 75N94020D00003 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV